Effect of preoperative chemotherapy on the DNA content in ovarian serous cystadenocarcinomas
Irzhanov, S.I.; Serov, S.F.
Voprosy Onkologii 27(8): 49-52
1981
ISSN/ISBN: 0507-3758 PMID: 6792783 Document Number: 170740
Document emailed within 1 workday
Related Documents
Takiguchi, N.; Souda, H.; Tonooka, T.; Ikeda, A.; Nabeya, Y.; Kainuma, O.; Saito, H.; Arimitsu, H.; Kobayashi, R.; Chibana, T.; Sasaki, K.; Ishige, F.; Nagata, M.; Yamamoto, H.; Denda, T. 2015: The Different Indications and Treatment Effect between Preoperative Chemotherapy and Preoperative Radiotherapy for Advanced Rectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1475-1478Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Živný, J.H.; Leahomschi, S.; Klener, P.; Živný, J.; Haluzík, M.; Cibula, D. 2016: Comparison of Plasma Osteopontin Levels between Patients with Borderline Ovarian Tumours and Serous Ovarian Carcinoma Folia Biologica 62(6): 258-262
Skodras, G.; Fields, V.; Kragel, P.J. 1994: Ovarian lymphoma and serous carcinoma of low malignant potential arising in the same ovary. A case report with literature review of 14 primary ovarian lymphomas Archives of Pathology and Laboratory Medicine 118(6): 647-650
Peng, Y.-Z.; Shen, K.; Wu, M.; Huang, H.-F.; Pan, L.-Y.; Yang, J.-X.; Lang, J.-H. 2005: Comparison of clinical characteristics of extraovarian peritoneal serous papillary carcinoma with papillary serous ovarian carcinoma Zhonghua Fu Chan Ke Za Zhi 40(4): 243-245
Ma, S.; Shen, K.; Lang, J. 2001: Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer Zhonghua Fu Chan Ke Za Zhi 36(3): 162-164
Cabrera, J.; Fluxá, L.; Pérez, C.; Ramírez, I.; Toledo, P.; Poloni, O. 1993: Effect of preoperative brachytherapy on estrogenic ovarian function, in patients with cervical neoplasms Revista Chilena de Obstetricia y Ginecologia 58(3): 220-227
Frid, I.A.; Turbina, I.L. 1972: The effect of anesthesia and surgical intervention on hematopoiesis following chemotherapy of malignant ovarian tumors Voprosy Onkologii 18(2): 91
Furuse, K.; Morimoto, K.; Yamamoto, K.; Orito, T. 1989: Application of preoperative chemotherapy to postoperative chemotherapy in malignant bone and soft tissue tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-3): 1749-1754
Onisim, A.; Iancu, M.; Vlad, C.; Kubelac, P.; Fetica, B.; Fulop, A.; Achimas-Cadariu, A.; Achimas-Cadariu, P. 2016: Expression of Nestin and CD133 in serous ovarian carcinoma Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1168-1175
Kolosov, A.E.; Chernina, L.A.; Bychkov, V.M. 1983: Ultrastructural characteristics of endometrioid and serous ovarian adenocarcinomas Arkhiv Patologii 45(8): 34-38
Ivanov, S.; Batashki, I. 2008: Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer Akusherstvo i Ginekologiia 47(5): 9-11
Stemberger-Papić, S.; Vrdoljak-Mozetic, D.; Ostojić, D.V.; Rubesa-Mihaljević, R.; Krigtofić, I.; Brncić-Fisher, A.; Kragević, M.; Eminović, S. 2015: Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases Collegium Antropologicum 39(3): 745-753
Garzetti, G.G.; Ciavattini, A.; Lucarini, G.; Goteri, G.; Romanini, C.; Biagini, G. 1996: Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125 Anticancer Research 16(4a): 2123-2127
Takeuchi, K.; Kitazawa, S.; Deguchi, M.; Maruo, T. 2005: Adenofibromasarcoma originating from a mural nodule of ovarian serous cystadenoma European Journal of Gynaecological Oncology 26(5): 511-513
Bacci, G.; Picci, P.; Gherlinzoni, F.; Van Horn, J.R.; Orlandi, M.; Normand, A.R.; Manfrini, M.; Pignatti, G.; Campanacci, M. 1986: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(2): 140-143
Zhang, J.; Guo, X.-q.; Liu, J.-s. 2011: Clinical significance of two-tier grading system of ovarian serous carcinoma Zhonghua Fu Chan Ke Za Zhi 46(10): 739-741
Yordanov, A.; Ivanov, I.; Popovska, S.; Dineva, T.; Dimitrov, T.; Ivanova, Z. 2013: Evaluation of the expression of S100A1 protein in serous, mucinous and endometroid ovarian carcinoma Akusherstvo i Ginekologiia 52(5): 22-26